Narrative review / 2024
COVID-19 pandemic-related societal changes increased adolescent obesity prevalence alongside new clinical guidelines and weight loss drug approvals.
Societal changes secondary to the COVID-19 pandemic led to an increased prevalence of adolescents with obesity along with heightened awareness of weight stigma and size bias. During this period, the American Academy of Pediatrics issued its first clinical practice guidelines and the FDA approved new weight loss drugs for adolescents, though insurance coverage remains largely unavailable.
- Study type
- Narrative review
- Who was studied
- Adolescents with obesity
- What was measured
- Post-pandemic weight management, guidelines, and drug approvals
THE PAPER
Obesity: Post-Pandemic Weight Management.
Swamy AM. Pediatr Clin North Am, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.